Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
XLO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
XLO
Xilio Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
XLO
Xilio Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
XLO: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only XLO
0
None
Shared
0
No disclosed counterparties: XLO.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR
XLO
Xilio Therapeutics, Inc.
Change
7.97
▼
−8.18%
· post 8.80
Mkt cap
$168.4M
Revenue
$19M
Q2 FY26
Revenue
$44M
FY25
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,421.02
Closed
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 4 '26
XLO
Xilio Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
7.97
▼
−8.18%
post 8.80
Price
1,417.89
▲
+0.60%
post 1,421.02
$168.4M
Mkt cap
$1.3T
Q2 FY26
$19M
Revenue
$24.4B
Q3 FY26
FY25
$44M
Revenue
$65.2B
FY25
Change
Change
XLO
7.97
▼
−8.18%
vs
LLY
1,417.89
▲
+0.60%
Closed
Nov 4 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
XLO, solid
LLY, dashed